Joaquin Keller

Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA.

Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Consorzio per il Centro di Biomedicina Molecolare SCRL develops local health programs. It manages projects and organizes activities in the biomedicine, biotechnology, and bioinformatics sectors. The company is headquartered in Trieste, Italy.

The Institute of Molecular & Cell Biology engages in biomedical research. The non-profit company is based in Singapore, Singapore.

Health Catalyst Capital Management LLC (Health Catalyst Capital) is a private equity and venture capital firm founded in 2015 by Charles Boorady. The firm is headquartered in New York.

Pulse Infoframe, Inc. operates as a cloud-based health care analytics company. Its products include dynamic registries, patient reported outcomes, visualizations and analytics, patient engagement portal. The firm's services include collaborative clinical research, workflow optimization, consulting, cloud enabled global sourcing, interoperability and deployment services. The company was founded by Femida Gwadry-Sridhar in 2011 and is headquartered in London, Canada.

Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom.

Xperiome Ltd. operates online community platform. Its services include online health communities, patient education, career education, and patient recruitment. The company was founded by Julie Walters and Peter Coe in 2007 and is headquartered in London, the United Kingdom.

Genialis, Inc. develops software for biologists in solving complex analyses. The software helps in automation of data and analyzing task for exploring and sharing the results. The company is headquartered in Houston, TX.

EspeRare Foundation offers treatments for rare diseases. The non-profit company is based in Geneva, Switzerland.

Duality Technologies, Inc. engages in privacy enhancing technologies. Its products include secure data analysis; IP protection for analytics models; and privacy-preserving data linkage. The company was founded by Alon Kaufman, Shafi Glodwasser, Rina Shainski, Kurt Rohloff, and Vinod Vaikuntanathan in 2016 and is headquartered in Maplewood, NJ.

Leapcure, Inc. is an American patient-centric clinical trial solutions company founded in 2015 by Zachary Gobst, Tyler Dornenburg, Kyle W Eaton, and Luis De Avila. The company is based in the United States and is committed to expediting patient recruitment and helping to bring vital treatments to the market faster. Leapcure connects patients and research to elevate the patient's voice in the process, delivering patient participation to accelerate research innovations. The company's approach is rooted in cutting-edge technology and deep industry knowledge, combining advanced data analytics, a hands-on patient care team, and patient advocacy partnerships to support patients, research sites, and biotech companies in their clinical research. Discover patient-centric clinical trial solutions at leapcure.com.

Reach52 Asia Pte Ltd. engages in the provision of accessible and affordable healthcare services to communities where healthcare access is limited. It offers services to communities, healthcare providers, governments, multi-laterals, and institutions. The company was founded by Ed Booty in 2017 and is headquartered in Singapore.

Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy.